Morgan Stanley Sci Sparc Ltd. Transaction History

Morgan Stanley

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.72 - $21.81 $27 - $828	-38 Reduced 95.0%	2 $0
Q1 2022 May 13, 2022	SELL	$3.5 - $6.73 $24 - $47	-7 Reduced 14.89%	40 $0
Q4 2021 Feb 14, 2022	BUY	$5.5 - $7.7 $258 - $361	47 New	47 $0

Ticker SPRC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 3,526,740
Market Cap $1.52M
Description
SciSparc Ltd., a specialty clinical-stage pharmaceutical company, develops drugs based on cannabinoid molecules. Its drug development programs include SCI-110 for the treatment of Tourette syndrome, obstructive sleep apnea, and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; and SCI-210 for the treatment of autism spectrum ...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.